Femasys Inc
NASDAQ:FEMY
Femasys Inc
NASDAQ:FEMY
Price:
1.21 USD
-4.72%
Market Closed
Updated:
May 13, 2024
Femasys Inc
Selling, General & Administrative
|
Femasys Inc
Selling, General & Administrative Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Femasys Inc
NASDAQ:FEMY
|
Selling, General & Administrative
-$7.5m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Selling, General & Administrative
-$4.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Selling, General & Administrative
-$5.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
|
Stryker Corp
NYSE:SYK
|
Selling, General & Administrative
-$7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Selling, General & Administrative
-$11.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Selling, General & Administrative
-$2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-12%
|
See Also
What is Femasys Inc's Selling, General & Administrative?
Selling, General & Administrative
-7.5m
USD
-7.5m
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Selling, General & Administrative amounts to -7.5m USD.
What is Femasys Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-38%
-38%
Over the last year, the Selling, General & Administrative growth was -25%. The average annual Selling, General & Administrative growth rates for Femasys Inc have been -38% over the past three years .
You don't have any saved screeners yet
